Precision Optics Corporation (POCI) Cash from Investing Activities (2010 - 2026)
Precision Optics Corporation (POCI) posted quarterly Cash from Investing Activities of $49492.0 for Q1 2026, up 155.14% year-over-year from $19397.7 in Q1 2025, and up 151.37% quarter-over-quarter from -$96342.0 in Q4 2025.
Precision Optics Corporation (POCI) Cash from Investing Activities (2010 - 2026) Analysis & Trends
Precision Optics Corporation (POCI) has reported Cash from Investing Activities for 17 consecutive years, with $49492.0 the latest figure, recorded in Q1 2026.
- In Q1 2026, Cash from Investing Activities rose 155.14% year-over-year to $49492.0; the TTM figure through Mar 2026 stood at -$432275.0 (down 167.43% YoY), while the FY2025 annual figure was -$233473.0, up 20.56% from the prior year.
- Cash from Investing Activities rose to $49492.0 in Q1 2026 per POCI's latest filing, from -$96342.0 in the prior quarter.
- Across five years, Cash from Investing Activities topped out at $96587.0 in Q2 2022 and bottomed at -$301789.0 in Q3 2025.
- Historically, Cash from Investing Activities has averaged -$61361.1 across 5 years, with a median of -$31986.0 in 2024.
- Annual changes were most pronounced in 2024 — Cash from Investing Activities plunged 13626.74% — and 2026, when it jumped 155.14%.
- Precision Optics Corporation's Cash from Investing Activities stood at -$8463.0 in 2022, then plunged by 1403.66% to -$127255.0 in 2023, then jumped by 74.86% to -$31986.0 in 2024, then slumped by 201.2% to -$96342.0 in 2025, then soared by 151.37% to $49492.0 in 2026.
- Business Quant data shows POCI's Cash from Investing Activities at $49492.0 in Q1 2026, -$96342.0 in Q4 2025, and -$301789.0 in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash from Investing Activities (Qtr) |
|---|---|---|---|---|---|
| 1 | Intuitive Surgical | 134.13 Bn | 128.91 Bn | 1.96 Bn | -26.60 Mn |
| 2 | Becton Dickinson | 52.76 Bn | 51.90 Bn | 2.32 Bn | -241.00 Mn |
| 3 | Alcon | 35.81 Bn | 34.46 Bn | 1.68 Bn | -222.00 Mn |
| 4 | Resmed | 33.72 Bn | 32.25 Bn | 861.22 Mn | -383.65 Mn |
| 5 | Medline | 29.38 Bn | 26.70 Bn | 2.22 Bn | -461.00 Mn |
| 6 | West Pharmaceutical Services | 25.00 Bn | 24.57 Bn | 329.20 Mn | -43.20 Mn |
| 7 | Solventum | 15.46 Bn | 15.06 Bn | 1.29 Bn | -87.00 Mn |
| 8 | Cooper Companies | 14.88 Bn | 14.74 Bn | 735.40 Mn | -90.00 Mn |
| 9 | Baxter International | 13.58 Bn | 11.43 Bn | 1.03 Bn | -117.00 Mn |
| 10 | Precision Optics Corporation | 35.46 Mn | 24.78 Mn | 2.06 Mn | 49,492.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 49,492.00 |
| Mar 31, 2026 | 49,492.00 |
| Dec 31, 2025 | -96,342.00 |
| Dec 31, 2025 | -96,342.00 |
| Sep 30, 2025 | -301,789.00 |
| Sep 30, 2025 | -301,789.00 |
| Jun 30, 2025 | -83,636.00 |
| Jun 30, 2025 | -83,636.00 |
| Mar 31, 2025 | -89,752.00 |
| Mar 31, 2025 | -89,752.00 |
| Dec 31, 2024 | -31,986.00 |
| Dec 31, 2024 | -31,986.00 |
| Sep 30, 2024 | -28,099.00 |
| Sep 30, 2024 | -28,099.00 |
| Jun 30, 2024 | -11,805.00 |
| Jun 30, 2024 | -11,805.00 |
| Mar 31, 2024 | -111,306.00 |
| Mar 31, 2024 | -111,306.00 |
| Dec 31, 2023 | -127,255.00 |
| Dec 31, 2023 | -127,255.00 |